Overview:
Antibiotics are used for treatment of bacterial infection, as they eliminate the growth of bacteria or the bacteria itself. Whereas, corticosteroids are used for treatment of inflammatory and allergy condition. Antibiotics can perform some functions that cannot be performed by corticosteroids and vice-versa. Sometimes, the doctors prescribe combined dose of antibiotics and corticosteroids so to attack microorganism cell wall with antibiotics and to tackle inflammatory process with the corticosteroids. Misuse or overdose of both the compounds can cause harmful side effects like immune system failure.
Drivers:
Government initiatives in the favour of manufacturing antibiotics and corticosteroids is expected to propel growth of the global antibiotics and corticosteroids market. For instance, the Antibiotics Incentives Now (GAIN) act introduced by the U.S. government provides provisions to enable development of treatment for antigen resistant pathogens which is likely to propel antibiotics approvals.
Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/781
Furthermore, the efficiency of combined therapy of corticosteroids and antibiotics in the treatment of numerous chronic diseases is also expected to boost growth of the global antibiotics and corticosteroids market. This combination treatment has proven efficient to treat human respiratory syncytial virus (hRSV) infection, S. Aureus arthritis, Cepacia syndrome, Ebola, and Zika Virus. In 2016, a data published in the Journal of Tropical Diseases and Public Health reported that about 6.3 million children died in 2013, out of which infectious diseases caused 51.8% deaths where pneumonia caused 935,000 deaths. However, the human Respiratory syncytial virus (RSV), which is related to acute lower respiratory infections (ALRI) affects around 3.4 million children.
Restraints:
Factors such as contrary effects of high intake or misuse of corticosteroids and antibiotics, guidelines and policies regarding use of antibiotics and corticosteroids as well as their use in animals that are later consumed by humans are expected to hinder growth of the global antibiotics and corticosteroids market.
Request Here For FREE PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/781
Trends:
Market players are adopting various strategies such as collaborations, partnerships, geographical expansion, and development of new products in order to have a strong position in the global market of antibiotics and corticosteroids. For instance, in 2016, Pfizer acquired development and commercialization rights of AstraZeneca.
Market Taxonomy:
The global antibiotics and corticosteroids market is divided by application, by end user, by antibiotics type, by disease type, and by region.
By application:
-
Humans
-
Veterinary
By end user:
-
Hospitals
-
Medical clinics
By antibiotic type:
-
Tetracycline
-
Macrolides
-
Beta-lactams
-
Lincosamides
-
Glycopeptides
-
Sulfonamides
-
Aminoglycosides
-
Others
By disease type:
-
Pneumonia
-
Human Respiratory syncytial virus (RSV) infection
-
Cepasia Syndrome
-
Sinus Infection
-
Aureus Arthritis
-
Others
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/781
Regional Analysis:
The antibiotics and corticosteroids market is regionally divided into North America, Europe, Latin America, Middle East, Africa, and Asia Pacific.
North America is expected to witness robust growth in the antibiotics and corticosteroids market owing to increasing cases of respiratory syncytial virus (RSV) infection and the growing requirement of antibiotic and corticosteroids treatment for these type of diseases. For instance, as estimated by the Centers for Disease Control and Prevention (CDC), RSV affects nearly 2.1 million children and causes 14,000 deaths in adult population per year.
Moreover, Latin America and Asia Pacific are also expected to witness strong growth in the market of antibiotics and corticosteroids market due to improvement in pharmaceutical industry.
Major players:
Major industry players functioning in the global antibiotics and corticosteroids market are Pfizer, Abbott Laboratories, Johnson & Johnson, Sumitomo, Astellas Pharma, Novartis, GlaxoSmithKline (GSK), Sanofi, Merck, AstraZeneca, and Cipla.
Reasons to Purchase this Report
• Current and future of global Antibiotics and Corticosteroids Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/781
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Antibiotics and Corticosteroids Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Antibiotics and Corticosteroids Industry Impact
Chapter 2 Global Antibiotics and Corticosteroids Competition by Types, Applications, and Top Regions and Countries
2.1 Global Antibiotics and Corticosteroids (Volume and Value) by Type
2.3 Global Antibiotics and Corticosteroids (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Antibiotics and Corticosteroids Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Antibiotics and Corticosteroids Market Analysis
Chapter 6 East Asia Antibiotics and Corticosteroids Market Analysis
Chapter 7 Europe Antibiotics and Corticosteroids Market Analysis
Chapter 8 South Asia Antibiotics and Corticosteroids Market Analysis
Chapter 9 Southeast Asia Antibiotics and Corticosteroids Market Analysis
Chapter 10 Middle East Antibiotics and Corticosteroids Market Analysis
Chapter 11 Africa Antibiotics and Corticosteroids Market Analysis
Chapter 12 Oceania Antibiotics and Corticosteroids Market Analysis
Chapter 13 South America Antibiotics and Corticosteroids Market Analysis
Chapter 14 Company Profiles and Key Figures in Antibiotics and Corticosteroids Business
Chapter 15 Global Antibiotics and Corticosteroids Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837